| Ngo Phan Md Inc | |
|
330 S Garfield Ave Ste 268 Alhambra CA 91801-3892 | |
| (626) 281-3265 | |
| (626) 281-3267 |
| Full Name | Ngo Phan Md Inc |
|---|---|
| Speciality | Internal Medicine |
| Location | 330 S Garfield Ave, Alhambra, California |
| Authorized Official Name and Position | Ngo Phan (PRESIDENT & CEO) |
| Authorized Official Contact | 6262813265 |
| Accepts Medicare Insurance | Yes. This clinic participates in medicare program and accept medicare insurance. |
| Mailing Address | Practice Location Address |
|---|---|
| Ngo Phan Md Inc 330 S Garfield Ave Ste 268 Alhambra CA 91801-3892 Ph: (626) 281-3265 | Ngo Phan Md Inc 330 S Garfield Ave Ste 268 Alhambra CA 91801-3892 Ph: (626) 281-3265 |
| NPI Number | 1952663114 |
|---|---|
| Provider Enumeration Date | 06/13/2012 |
| Last Update Date | 06/13/2012 |
| Medicare PECOS PAC ID | 0042460065 |
|---|---|
| Medicare Enrollment ID | O20121026000519 |
News Archive
Quest PharmaTech Inc., a pharmaceutical company developing and commercializing products for the treatment of cancer, today announced the dosing of the first patient under the Company's recently initiated Phase I clinical trial with SL052 Photodynamic Therapy in prostate cancer patients. The study will evaluate the localization, safety, tolerability and preliminary treatment response of SL052 photodynamic therapy in 18 patients with localized prostate cancer.
The Associated Press: The Supreme Court will hear a case to decide whether drug makers can be sued by families who claim their children have suffered health problems from vaccines, going against a 1986 federal law that shields drug makers from most lawsuits and instead sets up a federal vaccine court to handle disputes.
Affymetrix, Inc. today launched new Axiom myDesign Targeted Genotyping (TG) Arrays for the targeted genotyping market, enabling researchers to study mutations in disease pathways and characterize gene-gene interactions.
The Illinois "House voted 71-44 to borrow up to $4 billion to cover next year's payments to the five state-funded pension systems." Lawmakers also rejected a proposal to have "retired state employees paying premiums for their health-care coverage. Rep. Karen May, D-Highland Park, said the state could save $100 million a year by having retirees pay premiums, noting that 92 percent of them pay nothing now."
› Verified 4 days ago
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1952663114 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207R00000X | Internal Medicine | A6044 (California) | Primary |
| Provider Name | Ngo C Phan |
|---|---|
| Provider Type | Practitioner - Family Practice |
| Provider Identifiers | NPI Number: 1043269145 PECOS PAC ID: 4486628435 Enrollment ID: I20040824001462 |
News Archive
Quest PharmaTech Inc., a pharmaceutical company developing and commercializing products for the treatment of cancer, today announced the dosing of the first patient under the Company's recently initiated Phase I clinical trial with SL052 Photodynamic Therapy in prostate cancer patients. The study will evaluate the localization, safety, tolerability and preliminary treatment response of SL052 photodynamic therapy in 18 patients with localized prostate cancer.
The Associated Press: The Supreme Court will hear a case to decide whether drug makers can be sued by families who claim their children have suffered health problems from vaccines, going against a 1986 federal law that shields drug makers from most lawsuits and instead sets up a federal vaccine court to handle disputes.
Affymetrix, Inc. today launched new Axiom myDesign Targeted Genotyping (TG) Arrays for the targeted genotyping market, enabling researchers to study mutations in disease pathways and characterize gene-gene interactions.
The Illinois "House voted 71-44 to borrow up to $4 billion to cover next year's payments to the five state-funded pension systems." Lawmakers also rejected a proposal to have "retired state employees paying premiums for their health-care coverage. Rep. Karen May, D-Highland Park, said the state could save $100 million a year by having retirees pay premiums, noting that 92 percent of them pay nothing now."
› Verified 4 days ago
| Provider Name | Christina Duong |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1770830499 PECOS PAC ID: 2769634849 Enrollment ID: I20121219000109 |
News Archive
Quest PharmaTech Inc., a pharmaceutical company developing and commercializing products for the treatment of cancer, today announced the dosing of the first patient under the Company's recently initiated Phase I clinical trial with SL052 Photodynamic Therapy in prostate cancer patients. The study will evaluate the localization, safety, tolerability and preliminary treatment response of SL052 photodynamic therapy in 18 patients with localized prostate cancer.
The Associated Press: The Supreme Court will hear a case to decide whether drug makers can be sued by families who claim their children have suffered health problems from vaccines, going against a 1986 federal law that shields drug makers from most lawsuits and instead sets up a federal vaccine court to handle disputes.
Affymetrix, Inc. today launched new Axiom myDesign Targeted Genotyping (TG) Arrays for the targeted genotyping market, enabling researchers to study mutations in disease pathways and characterize gene-gene interactions.
The Illinois "House voted 71-44 to borrow up to $4 billion to cover next year's payments to the five state-funded pension systems." Lawmakers also rejected a proposal to have "retired state employees paying premiums for their health-care coverage. Rep. Karen May, D-Highland Park, said the state could save $100 million a year by having retirees pay premiums, noting that 92 percent of them pay nothing now."
› Verified 4 days ago
| Provider Name | Andrew S Lam |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1568787216 PECOS PAC ID: 7719139757 Enrollment ID: I20121220000206 |
News Archive
Quest PharmaTech Inc., a pharmaceutical company developing and commercializing products for the treatment of cancer, today announced the dosing of the first patient under the Company's recently initiated Phase I clinical trial with SL052 Photodynamic Therapy in prostate cancer patients. The study will evaluate the localization, safety, tolerability and preliminary treatment response of SL052 photodynamic therapy in 18 patients with localized prostate cancer.
The Associated Press: The Supreme Court will hear a case to decide whether drug makers can be sued by families who claim their children have suffered health problems from vaccines, going against a 1986 federal law that shields drug makers from most lawsuits and instead sets up a federal vaccine court to handle disputes.
Affymetrix, Inc. today launched new Axiom myDesign Targeted Genotyping (TG) Arrays for the targeted genotyping market, enabling researchers to study mutations in disease pathways and characterize gene-gene interactions.
The Illinois "House voted 71-44 to borrow up to $4 billion to cover next year's payments to the five state-funded pension systems." Lawmakers also rejected a proposal to have "retired state employees paying premiums for their health-care coverage. Rep. Karen May, D-Highland Park, said the state could save $100 million a year by having retirees pay premiums, noting that 92 percent of them pay nothing now."
› Verified 4 days ago
| Provider Name | Susan Mendoza |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1124426127 PECOS PAC ID: 1557684966 Enrollment ID: I20141216000168 |
News Archive
Quest PharmaTech Inc., a pharmaceutical company developing and commercializing products for the treatment of cancer, today announced the dosing of the first patient under the Company's recently initiated Phase I clinical trial with SL052 Photodynamic Therapy in prostate cancer patients. The study will evaluate the localization, safety, tolerability and preliminary treatment response of SL052 photodynamic therapy in 18 patients with localized prostate cancer.
The Associated Press: The Supreme Court will hear a case to decide whether drug makers can be sued by families who claim their children have suffered health problems from vaccines, going against a 1986 federal law that shields drug makers from most lawsuits and instead sets up a federal vaccine court to handle disputes.
Affymetrix, Inc. today launched new Axiom myDesign Targeted Genotyping (TG) Arrays for the targeted genotyping market, enabling researchers to study mutations in disease pathways and characterize gene-gene interactions.
The Illinois "House voted 71-44 to borrow up to $4 billion to cover next year's payments to the five state-funded pension systems." Lawmakers also rejected a proposal to have "retired state employees paying premiums for their health-care coverage. Rep. Karen May, D-Highland Park, said the state could save $100 million a year by having retirees pay premiums, noting that 92 percent of them pay nothing now."
› Verified 4 days ago
| Provider Name | Jessica Wang |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1003299033 PECOS PAC ID: 8527377431 Enrollment ID: I20151015001624 |
News Archive
Quest PharmaTech Inc., a pharmaceutical company developing and commercializing products for the treatment of cancer, today announced the dosing of the first patient under the Company's recently initiated Phase I clinical trial with SL052 Photodynamic Therapy in prostate cancer patients. The study will evaluate the localization, safety, tolerability and preliminary treatment response of SL052 photodynamic therapy in 18 patients with localized prostate cancer.
The Associated Press: The Supreme Court will hear a case to decide whether drug makers can be sued by families who claim their children have suffered health problems from vaccines, going against a 1986 federal law that shields drug makers from most lawsuits and instead sets up a federal vaccine court to handle disputes.
Affymetrix, Inc. today launched new Axiom myDesign Targeted Genotyping (TG) Arrays for the targeted genotyping market, enabling researchers to study mutations in disease pathways and characterize gene-gene interactions.
The Illinois "House voted 71-44 to borrow up to $4 billion to cover next year's payments to the five state-funded pension systems." Lawmakers also rejected a proposal to have "retired state employees paying premiums for their health-care coverage. Rep. Karen May, D-Highland Park, said the state could save $100 million a year by having retirees pay premiums, noting that 92 percent of them pay nothing now."
› Verified 4 days ago
| Provider Name | Paveena Rungruangbangchan |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1225400146 PECOS PAC ID: 2466753181 Enrollment ID: I20151222000504 |
News Archive
Quest PharmaTech Inc., a pharmaceutical company developing and commercializing products for the treatment of cancer, today announced the dosing of the first patient under the Company's recently initiated Phase I clinical trial with SL052 Photodynamic Therapy in prostate cancer patients. The study will evaluate the localization, safety, tolerability and preliminary treatment response of SL052 photodynamic therapy in 18 patients with localized prostate cancer.
The Associated Press: The Supreme Court will hear a case to decide whether drug makers can be sued by families who claim their children have suffered health problems from vaccines, going against a 1986 federal law that shields drug makers from most lawsuits and instead sets up a federal vaccine court to handle disputes.
Affymetrix, Inc. today launched new Axiom myDesign Targeted Genotyping (TG) Arrays for the targeted genotyping market, enabling researchers to study mutations in disease pathways and characterize gene-gene interactions.
The Illinois "House voted 71-44 to borrow up to $4 billion to cover next year's payments to the five state-funded pension systems." Lawmakers also rejected a proposal to have "retired state employees paying premiums for their health-care coverage. Rep. Karen May, D-Highland Park, said the state could save $100 million a year by having retirees pay premiums, noting that 92 percent of them pay nothing now."
› Verified 4 days ago
| Provider Name | Zhiguo Jacob Li |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1730553884 PECOS PAC ID: 4284933011 Enrollment ID: I20160429000917 |
News Archive
Quest PharmaTech Inc., a pharmaceutical company developing and commercializing products for the treatment of cancer, today announced the dosing of the first patient under the Company's recently initiated Phase I clinical trial with SL052 Photodynamic Therapy in prostate cancer patients. The study will evaluate the localization, safety, tolerability and preliminary treatment response of SL052 photodynamic therapy in 18 patients with localized prostate cancer.
The Associated Press: The Supreme Court will hear a case to decide whether drug makers can be sued by families who claim their children have suffered health problems from vaccines, going against a 1986 federal law that shields drug makers from most lawsuits and instead sets up a federal vaccine court to handle disputes.
Affymetrix, Inc. today launched new Axiom myDesign Targeted Genotyping (TG) Arrays for the targeted genotyping market, enabling researchers to study mutations in disease pathways and characterize gene-gene interactions.
The Illinois "House voted 71-44 to borrow up to $4 billion to cover next year's payments to the five state-funded pension systems." Lawmakers also rejected a proposal to have "retired state employees paying premiums for their health-care coverage. Rep. Karen May, D-Highland Park, said the state could save $100 million a year by having retirees pay premiums, noting that 92 percent of them pay nothing now."
› Verified 4 days ago
| Provider Name | Weizhen Li |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1679131874 PECOS PAC ID: 3678809217 Enrollment ID: I20190719001647 |
News Archive
Quest PharmaTech Inc., a pharmaceutical company developing and commercializing products for the treatment of cancer, today announced the dosing of the first patient under the Company's recently initiated Phase I clinical trial with SL052 Photodynamic Therapy in prostate cancer patients. The study will evaluate the localization, safety, tolerability and preliminary treatment response of SL052 photodynamic therapy in 18 patients with localized prostate cancer.
The Associated Press: The Supreme Court will hear a case to decide whether drug makers can be sued by families who claim their children have suffered health problems from vaccines, going against a 1986 federal law that shields drug makers from most lawsuits and instead sets up a federal vaccine court to handle disputes.
Affymetrix, Inc. today launched new Axiom myDesign Targeted Genotyping (TG) Arrays for the targeted genotyping market, enabling researchers to study mutations in disease pathways and characterize gene-gene interactions.
The Illinois "House voted 71-44 to borrow up to $4 billion to cover next year's payments to the five state-funded pension systems." Lawmakers also rejected a proposal to have "retired state employees paying premiums for their health-care coverage. Rep. Karen May, D-Highland Park, said the state could save $100 million a year by having retirees pay premiums, noting that 92 percent of them pay nothing now."
› Verified 4 days ago
| Provider Name | Richard Saavedra Tan |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1548936602 PECOS PAC ID: 0749687788 Enrollment ID: I20210917002541 |
News Archive
Quest PharmaTech Inc., a pharmaceutical company developing and commercializing products for the treatment of cancer, today announced the dosing of the first patient under the Company's recently initiated Phase I clinical trial with SL052 Photodynamic Therapy in prostate cancer patients. The study will evaluate the localization, safety, tolerability and preliminary treatment response of SL052 photodynamic therapy in 18 patients with localized prostate cancer.
The Associated Press: The Supreme Court will hear a case to decide whether drug makers can be sued by families who claim their children have suffered health problems from vaccines, going against a 1986 federal law that shields drug makers from most lawsuits and instead sets up a federal vaccine court to handle disputes.
Affymetrix, Inc. today launched new Axiom myDesign Targeted Genotyping (TG) Arrays for the targeted genotyping market, enabling researchers to study mutations in disease pathways and characterize gene-gene interactions.
The Illinois "House voted 71-44 to borrow up to $4 billion to cover next year's payments to the five state-funded pension systems." Lawmakers also rejected a proposal to have "retired state employees paying premiums for their health-care coverage. Rep. Karen May, D-Highland Park, said the state could save $100 million a year by having retirees pay premiums, noting that 92 percent of them pay nothing now."
› Verified 4 days ago
| Provider Name | Thanh Le Hoai Nguyen |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1518572007 PECOS PAC ID: 7911399316 Enrollment ID: I20220114001595 |
News Archive
Quest PharmaTech Inc., a pharmaceutical company developing and commercializing products for the treatment of cancer, today announced the dosing of the first patient under the Company's recently initiated Phase I clinical trial with SL052 Photodynamic Therapy in prostate cancer patients. The study will evaluate the localization, safety, tolerability and preliminary treatment response of SL052 photodynamic therapy in 18 patients with localized prostate cancer.
The Associated Press: The Supreme Court will hear a case to decide whether drug makers can be sued by families who claim their children have suffered health problems from vaccines, going against a 1986 federal law that shields drug makers from most lawsuits and instead sets up a federal vaccine court to handle disputes.
Affymetrix, Inc. today launched new Axiom myDesign Targeted Genotyping (TG) Arrays for the targeted genotyping market, enabling researchers to study mutations in disease pathways and characterize gene-gene interactions.
The Illinois "House voted 71-44 to borrow up to $4 billion to cover next year's payments to the five state-funded pension systems." Lawmakers also rejected a proposal to have "retired state employees paying premiums for their health-care coverage. Rep. Karen May, D-Highland Park, said the state could save $100 million a year by having retirees pay premiums, noting that 92 percent of them pay nothing now."
› Verified 4 days ago
| Provider Name | Lizette Cabral |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1467067447 PECOS PAC ID: 4880068600 Enrollment ID: I20230317002443 |
News Archive
Quest PharmaTech Inc., a pharmaceutical company developing and commercializing products for the treatment of cancer, today announced the dosing of the first patient under the Company's recently initiated Phase I clinical trial with SL052 Photodynamic Therapy in prostate cancer patients. The study will evaluate the localization, safety, tolerability and preliminary treatment response of SL052 photodynamic therapy in 18 patients with localized prostate cancer.
The Associated Press: The Supreme Court will hear a case to decide whether drug makers can be sued by families who claim their children have suffered health problems from vaccines, going against a 1986 federal law that shields drug makers from most lawsuits and instead sets up a federal vaccine court to handle disputes.
Affymetrix, Inc. today launched new Axiom myDesign Targeted Genotyping (TG) Arrays for the targeted genotyping market, enabling researchers to study mutations in disease pathways and characterize gene-gene interactions.
The Illinois "House voted 71-44 to borrow up to $4 billion to cover next year's payments to the five state-funded pension systems." Lawmakers also rejected a proposal to have "retired state employees paying premiums for their health-care coverage. Rep. Karen May, D-Highland Park, said the state could save $100 million a year by having retirees pay premiums, noting that 92 percent of them pay nothing now."
› Verified 4 days ago
| Provider Name | Jackeline Tekin |
|---|---|
| Provider Type | Practitioner - Family Practice |
| Provider Identifiers | NPI Number: 1033993597 PECOS PAC ID: 1951745942 Enrollment ID: I20240218000059 |
News Archive
Quest PharmaTech Inc., a pharmaceutical company developing and commercializing products for the treatment of cancer, today announced the dosing of the first patient under the Company's recently initiated Phase I clinical trial with SL052 Photodynamic Therapy in prostate cancer patients. The study will evaluate the localization, safety, tolerability and preliminary treatment response of SL052 photodynamic therapy in 18 patients with localized prostate cancer.
The Associated Press: The Supreme Court will hear a case to decide whether drug makers can be sued by families who claim their children have suffered health problems from vaccines, going against a 1986 federal law that shields drug makers from most lawsuits and instead sets up a federal vaccine court to handle disputes.
Affymetrix, Inc. today launched new Axiom myDesign Targeted Genotyping (TG) Arrays for the targeted genotyping market, enabling researchers to study mutations in disease pathways and characterize gene-gene interactions.
The Illinois "House voted 71-44 to borrow up to $4 billion to cover next year's payments to the five state-funded pension systems." Lawmakers also rejected a proposal to have "retired state employees paying premiums for their health-care coverage. Rep. Karen May, D-Highland Park, said the state could save $100 million a year by having retirees pay premiums, noting that 92 percent of them pay nothing now."
› Verified 4 days ago
News Archive
Quest PharmaTech Inc., a pharmaceutical company developing and commercializing products for the treatment of cancer, today announced the dosing of the first patient under the Company's recently initiated Phase I clinical trial with SL052 Photodynamic Therapy in prostate cancer patients. The study will evaluate the localization, safety, tolerability and preliminary treatment response of SL052 photodynamic therapy in 18 patients with localized prostate cancer.
The Associated Press: The Supreme Court will hear a case to decide whether drug makers can be sued by families who claim their children have suffered health problems from vaccines, going against a 1986 federal law that shields drug makers from most lawsuits and instead sets up a federal vaccine court to handle disputes.
Affymetrix, Inc. today launched new Axiom myDesign Targeted Genotyping (TG) Arrays for the targeted genotyping market, enabling researchers to study mutations in disease pathways and characterize gene-gene interactions.
The Illinois "House voted 71-44 to borrow up to $4 billion to cover next year's payments to the five state-funded pension systems." Lawmakers also rejected a proposal to have "retired state employees paying premiums for their health-care coverage. Rep. Karen May, D-Highland Park, said the state could save $100 million a year by having retirees pay premiums, noting that 92 percent of them pay nothing now."
› Verified 4 days ago
Ssg Apctc Alhambra Center Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 1635 W Main St Ste 100, Alhambra, CA 91801 Phone: 626-248-1800 | |
Patient Care Medical Center Inc Primary Care Clinic Medicare: Medicare Enrolled Practice Location: 320 S Garfield Ave Ste 206, Alhambra, CA 91801 Phone: 626-607-9406 Fax: 626-458-2489 | |
Thelma V Buan Md Inc Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 123 N Garfield Ave, Suite C, Alhambra, CA 91801 Phone: 626-308-3781 Fax: 626-308-2113 | |
Paul Hovsepian, M.d. Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 103 N Garfield Ave, Suite F, Alhambra, CA 91801 Phone: 626-282-2100 Fax: 626-281-0969 | |
Thida Win Md Inc Primary Care Clinic Medicare: Medicare Enrolled Practice Location: 100 S Raymond Ave, Alhambra, CA 91801 Phone: 626-677-8218 | |
Apc-lsma Designated Shareholder Medical Corporation Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 925 S Garfield Ave, Alhambra, CA 91801 Phone: 626-282-0282 | |
Ap-amh 2 Medical Corporation Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 1668 S Garfield Ave Fl 2, Alhambra, CA 91801 Phone: 626-282-0288 |